,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu']
asco: enhertu to transform breast cancer with her2-low show 
PhD of Pharm-Science. Visiting scholar at department of bioengineering. Nanomedicine and biomaterials